Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Younis, Nancy S., Ghanim, Amal M. H., Saber, Sameh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365839/
https://www.ncbi.nlm.nih.gov/pubmed/35948610
http://dx.doi.org/10.1038/s41598-022-17580-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365839/
https://www.ncbi.nlm.nih.gov/pubmed/35948610
http://dx.doi.org/10.1038/s41598-022-17580-7

Ejemplares similares